These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 3758091)

  • 1. Clinical cardiac electrophysiology of indoramin, a post-synaptic alpha blocker.
    Butrous GS; Camm AJ
    Eur Heart J; 1986 Jul; 7(7):576-83. PubMed ID: 3758091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical cardiac electrophysiological assessment of indoramin.
    Butrous GS; Camm AJ
    J Cardiovasc Pharmacol; 1986; 8 Suppl 2():S137-43. PubMed ID: 2423787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experimental evidence for the antiarrhythmic action of indoramin.
    Harron DW
    J Cardiovasc Pharmacol; 1986; 8 Suppl 2():S131-6. PubMed ID: 2423786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigations into the bradycardic action of indoramin.
    Lillie C; Harron DW; Kobinger W
    Arzneimittelforschung; 1985; 35(1A):301-5. PubMed ID: 4039170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiarrhythmic and proarrhythmic properties of diazepam demonstrated by electrophysiological study in humans.
    Kumagai K; Yamanouchi Y; Matsuo K; Tashiro N; Hiroki T; Arakawa K
    Clin Cardiol; 1991 May; 14(5):397-401. PubMed ID: 2049890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electrophysiological effects of prenalterol on the cardiac conduction system.
    Dahlström U; Lassvik C
    Eur Heart J; 1983 Oct; 4(10):728-32. PubMed ID: 6653583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation into the cardioregulatory properties of the alpha 1-adrenoceptor blocker indoramin.
    Pierce V; Shepperson NB; Todd MH; Waterfall JF
    Br J Pharmacol; 1986 Feb; 87(2):433-41. PubMed ID: 3955309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of indoramin, labetalol and alinidine on sympathetic function in normal man.
    Nicholls DP; McNeill J; O'Connor PC; Harron DW; Leahey WJ; Shanks RG
    Br J Clin Pharmacol; 1984 Aug; 18(2):215-21. PubMed ID: 6386022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current concepts in the treatment of cardiac arrhythmias.
    Manz M; Wagner WL; Grube E; Lüderitz B
    J Cardiovasc Pharmacol; 1986; 8 Suppl 2():S124-30. PubMed ID: 2423785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential blockade of alpha-adrenoceptors by indoramin.
    Nicholls DP; O'Connor PC; Harron DW; Leahey WJ; Shanks RG
    Br J Clin Pharmacol; 1984 Jun; 17(6):719-28. PubMed ID: 6146328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemodynamic responses to indoramin at rest and during exercise in congestive heart failure.
    Leier CV; Majetich N; Binkley PF; Uverferth DV
    Pharmacotherapy; 1987; 7(3):61-8. PubMed ID: 3628063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrophysiological effects of intravenous prostacyclin in man.
    Perrot B; Clozel JP; de la Chaise AT; Cherrier F; Faivre G
    Eur Heart J; 1984 Nov; 5(11):883-9. PubMed ID: 6397357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-arrhythmic properties of the alpha-adrenoceptor blocking drug indoramin.
    James MA; Jones JV
    Br J Clin Pharmacol; 1991 Sep; 32(3):375-8. PubMed ID: 1685666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of acute and chronic indoramin administration on baroreflex function and tremor in humans.
    Deering AH; Riddell JG; Harron DW; Shanks RG
    J Cardiovasc Pharmacol; 1988 Mar; 11(3):284-90. PubMed ID: 2452920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of indoramin on finger blood flow in vasospastic patients.
    Clement DL
    Eur J Clin Pharmacol; 1978 Dec; 14(5):331-3. PubMed ID: 729626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Changes of heart electrophysiological parameters after destruction of epicardial subplexuses that innervate sinoatrial node].
    Kulboka A; Veikutis V; Pauza DH; Lekas R
    Medicina (Kaunas); 2003; 39(6):589-95. PubMed ID: 12829884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coronary blood flow during exercise following nonselective and selective alpha 1-adrenergic blockade with indoramin.
    Dai XZ; Herzog CA; Schwartz JS; Bache RJ
    J Cardiovasc Pharmacol; 1986; 8(3):574-81. PubMed ID: 2425176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On the mechanisms of hypotensive action of indoramin.
    Gulati K; Srimal RC; Dhawan BN
    Pol J Pharmacol Pharm; 1978; 30(6):811-8. PubMed ID: 755245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation into mechanism of lack of reflex tachycardia in response to hypotensive action of indoramin in dogs.
    Harron DW; Kerr MJ; Shanks RG
    J Cardiovasc Pharmacol; 1984; 6(4):596-600. PubMed ID: 6206312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The electrophysiological effects of flosequinan.
    Bashir Y; O'Nunain S; Paul VE; Butrous GS; Ward DE; Camm AJ
    Eur Heart J; 1991 Dec; 12(12):1288-92. PubMed ID: 1778194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.